Why Digital Trust Will Decide The Winners And Losers Of The AI Economy

Technology will continue to evolve, but trust is what will shape markets, guide regulation, attract investment and determine ...

The great programming transformation: How AI and Rust are quietly dethroning C in Linux - and Windows

Maintainers and developers are now using AI to help build Linux. Simultaneously, Rust has graduated to being a co-equal language with C for mainstream Linux development. However, the programming world ...
Hackaday

Different Algorithms Sort Christmas Lights

Sorting algorithms are a common exercise for new programmers, and for good reason: they introduce many programming ...
IEEE

Efficient Data Structures and Algorithms for Cloud Computing Platforms

Abstract: The extensive adoption of cloud computing platforms in storing and processing data have brought forth a new age of efficiency in the way data is stored, processed and managed, requiring new ...
rowan

Online BS in Data Analytics

Strengthen your skills in skills in data collection, exploration, analysis, visualization, presentation and dissemination as a student in our flexible, fully online bachelor's degree in data analytics ...
IEEE

Open-Structure: Structural Benchmark Dataset for SLAM Algorithms

Abstract: This letter presents Open-Structure, a novel benchmark dataset for evaluating visual odometry and SLAM methods. Compared to existing public datasets that primarily offer raw images, ...
Seeking Alpha

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Seeking Alpha

Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...